Articles from Impact Biomedical, Inc.
Impact Biomedical Inc. and Zoar Limited Announce SEC Declaration of Effectiveness of Form F-4 Registration Statement, Marking Major Milestone Toward Closing of Proposed Business Combination
Special meeting of Impact Biomedical stockholders to approve the proposed Business Combination scheduled for November 13, 2026, at 10:00 a.m. Eastern Standard TimeUpon closing, the combined company is expected to operate as Zoar Limited and trade on NYSE American under the ticker symbol "ZOAR," subject to listing approval
By Impact Biomedical, Inc. · Via ACCESS Newswire · November 2, 2026